Skip to main content
Premium Trial:

Request an Annual Quote

Top 10 Articles on GenomeWeb in 2017: Supreme Court Ruling; FDA Guidelines for Precision Med; More

NEW YORK (GenomeWeb) – What were the articles that gained the most interest from GenomeWeb readers this past year? The list is a cross-section of our coverage including a US Supreme Court decision, FDA guidelines, coverage of the JP Morgan Healthcare Conference, a notable acquisition, and a study of circulating tumor DNA for detecting early cancers, among others.

 Here are the top 10:

1)    Supreme Court Rules in Favor of Life Technologies in DNA Kit Component Case

2)    JPM Healthcare Day Two: 10x Genomics, Foundation Med, Quidel, Hologic, LabCorp, Nanostring, Bio-Rad

3)    FDA Releases Draft Guidelines to Clarify Regulatory Framework Supporting Precision Medicine

4)    Thermo Fisher Next-Gen Sequencing Panel Wins FDA Approval as Companion Test

5)    Illumina Launches NextSeq 550Dx, Expands Use of MiSeqDx

6)    Bio-Rad to Acquire RainDance Technologies

7)    Illumina Unveils New High-Throughput Sequencing Instrument at JP Morgan

8)    Counsyl Lays Off Oncology Sales Team

9)    FDA's Personalized Medicine Leader Leaving for Liquid Biopsy Startup Grail

10)  Sequencing of Circulating Tumor DNA Detects Early Cancers

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.